439 kr

Beställningsvara. Skickas inom 11-20 vardagar
Fri frakt för medlemmar vid köp för minst 249 kr.
Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and provide a more focused and rational pathway to drug development. On October 24, 2008, the IOM's Forum on Drug Discovery, Development, and Translation held "Assessing and Accelerating Development of Biomarkers for Drug Safety," a one-day workshop, summarized in this volume, on the value of biomarkers in helping to determine drug safety during development.

Produktinformation

  • Utgivningsdatum2009-08-20
  • Mått152 x 229 x undefined mm
  • SpråkEngelska
  • Antal sidor100
  • FörlagNational Academies Press
  • EAN9780309131247

Mer från samma författare

Innovation in Drug Research and Development for Prevalent Chronic Diseases

Innovation in Drug Research and Development for Prevalent Chronic Diseases

and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, National Academies of Sciences Engineeri, National Academies of Sciences Engineering and Medicine, Health And Medicine Division, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation, Carolyn Shore, Robert Pool, Amanda Wagner Gee, Andrew March

449 kr

Adverse Drug Event Reporting

Adverse Drug Event Reporting

Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Institute Of Medicine, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation, Adrienne Stith Butler, Heather Begg, Jennifer Rainey, Jeffrey M. Drazen

439 kr

Understanding the Benefits and Risks of Pharmaceuticals

Understanding the Benefits and Risks of Pharmaceuticals

and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy, Institute of Medicine, Institute Of Medicine, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation, Leslie Pray

439 kr

Addressing the Barriers to Pediatric Drug Development

Addressing the Barriers to Pediatric Drug Development

and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy, Institute of Medicine, Institute Of Medicine, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation, Andrea Knutsen, Adrienne Stith Butler, Cori Vanchieri

439 kr

Breakthrough Business Models

Breakthrough Business Models

Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Robert Giffin, Sally Robinson, Theresa Wizemann, Institute Of Medicine, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation

679 kr

Public Health Emergency Medical Countermeasures Enterprise

Public Health Emergency Medical Countermeasures Enterprise

Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Forum on Medical and Public Health Preparedness for Catastrophic Events, Institute Of Medicine, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation, Bruce M. Altevogt, Clare Stroud, Theresa Wizemann

909 kr

Transforming Clinical Research in the United States

Transforming Clinical Research in the United States

Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Institute Of Medicine, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation, Robert B. Giffin, Yeonwoo Lebovitz, Rebecca A. English

689 kr

Building a National Framework for the Establishment of Regulatory Science for Drug Development

Building a National Framework for the Establishment of Regulatory Science for Drug Development

Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Institute of Medicine, Institute Of Medicine, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation, Yeonwoo Lebovitz, Rebecca English, Anne Claiborne

439 kr

Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa

Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa

Academy of Science of South Africa, Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Institute Of Medicine, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation, Anne Claiborne, Yeonwoo Lebovitz, Steve Olson

659 kr

Direct-To-Consumer Genetic Testing

Direct-To-Consumer Genetic Testing

and Law Committee on Science, Technology, and Translation Forum on Drug Discovery, Development, Roundtable on Translating Genomic-Based Research for Health, Board on Life Sciences, Board on Health Sciences Policy, Policy and Global Affairs, Division on Earth and Life Studies, National Research Council, Institute of Medicine, Policy And Global Affairs, Committee on Science Technology and Law, Institute Of Medicine, Board On Health Care Services, National Cancer Policy Forum, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation, Division On Earth And Life Studies, Board On Life Sciences, Anne-Marie Mazza, Mary Fraker

529 kr

Du kanske också är intresserad av

Deriving Drug Discovery Value from Large-Scale Genetic Bioresources

Deriving Drug Discovery Value from Large-Scale Genetic Bioresources

and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Roundtable on Genomics and Precision Health, National Academies of Sciences Engineeri, National Academies of Sciences Engineering and Medicine, Health And Medicine Division, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation, Sarah H. Beachy, Steve Olson, Amanda Wagner Gee, Siobhan Addie

619 kr

Addressing the Threat of Drug-Resistant Tuberculosis

Addressing the Threat of Drug-Resistant Tuberculosis

Institute of Medicine, Institute Of Medicine, Sally Robinson, Robert Giffin

749 kr

Accelerating the Development of New Drugs and Diagnostics

Accelerating the Development of New Drugs and Diagnostics

Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Institute Of Medicine, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation, Anne B. Claiborne, Steve Olson

549 kr

Sharing Clinical Research Data

Sharing Clinical Research Data

and Translation Forum on Drug Discovery, Development, Forum on Neuroscience and Nervous System Disorders, National Cancer Policy Forum, Roundtable on Translating Genomic-Based Research on Health, Board on Health Sciences Policy, Board on Health Care Services, Institute of Medicine, Institute Of Medicine, Board On Health Care Services, Board On Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Forum on Drug Discovery Development and Translation, Steve Olson, Autumn Downey

579 kr

Facing the Reality of Drug-Resistant Tuberculosis in India

Facing the Reality of Drug-Resistant Tuberculosis in India

Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Institute Of Medicine, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation, Anne B. Claiborne, Rita S. Guenther, Rebecca A. English, Steve Olson

719 kr

Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa

Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa

Academy of Science of South Africa, Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Institute Of Medicine, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation, Anne Claiborne, Yeonwoo Lebovitz, Steve Olson

659 kr

Breakthrough Business Models

Breakthrough Business Models

Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Robert Giffin, Sally Robinson, Theresa Wizemann, Institute Of Medicine, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation

679 kr

Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development

Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development

Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Institute Of Medicine, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation, Anne B. Claiborne, Steve Olson

469 kr

New Profile of Drug-Resistant Tuberculosis in Russia

New Profile of Drug-Resistant Tuberculosis in Russia

Russian Academy of Medical Sciences, Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Institute Of Medicine, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation, Anne Claiborne, Rebecca English, Steve Olson

529 kr

Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS

Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS

and Translation Forum on Drug Discovery, Development, Board on Health Sciences Policy, Institute of Medicine, Institute Of Medicine, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation, Steve Olson, Rebecca A. English, Anne B. Claiborne

659 kr

Tillhör följande kategorier